Media Articles Related to Qutenza (Capsaicin)
Data presented at NANS 2014 demonstrate long-term, low back pain relief with Spectra Spinal Cord Stimulator System
Source: Medical Devices / Diagnostics News From Medical News Today [2014.12.20]
New retrospective data evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate that the device provided sustained, highly...
Novel agent decreases neuropathic pain in patients with type 2 diabetes
Source: Diabetes News From Medical News Today [2014.12.19]
Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2...
The difficulties of treating shoulder pain in baseball pitchers
Source: Bones / Orthopedics News From Medical News Today [2014.12.15]
Results of treating shoulder pain in baseball pitchers and other throwing athletes are not as predictable as doctors, patients and coaches would like to think, according to a report in the journal...
Commonly prescribed painkiller not effective in controlling lower back pain
Source: Seniors / Aging News From Medical News Today [2014.12.15]
A new study in the journal Neurology shows that pregabalin is not effective in controlling the pain associated with lumbar spinal stenosis, the most common type of chronic lower back pain in older...
Painful Hands, Hurting Hearts?
Source: MedPage Today Rheumatology [2014.12.15]
(MedPage Today) -- Symptomatic hand osteoarthritis was linked with coronary heart disease.
Published Studies Related to Qutenza (Capsaicin)
Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary
hypertension patients. 
trepostinil-induced pain... CONCLUSIONS: Further investigation of the efficacy of capsaicin 8% patch in this
Diclofenac with or without an antiemetic for acute migraine headaches in adults. 
CONCLUSIONS: Oral diclofenac potassium 50 mg is an effective treatment
Topical capsaicin (low concentration) for chronic neuropathic pain in adults. 
CONCLUSIONS: There were insufficient data to draw any conclusions about
Capsaicin instillation for postoperative pain following total knee arthroplasty: a preliminary report of a randomized, double-blind, parallel-group, placebo-controlled, multicentre trial. [2011.12.01]
BACKGROUND: Pain following total knee arthroplasty (TKA) interferes with rehabilitation. Capsaicin applied in high concentration to nociceptors can cause relatively selective C-fibre desensitization for a period of weeks to months. Resultant long-lasting analgesia might facilitate rehabilitation. OBJECTIVE: The objective of this study was to determine if direct instillation of a high-concentration capsaicin preparation into the wound following TKA would provide pain relief, improve physical functioning and rehabilitation, and reduce opioid requirements... CONCLUSION: Despite having higher BMIs, patients in the capsaicin group achieved comparable or better pain scores with significantly less opioid use in the first 3 postoperative days. They also had less pruritus, which may have been a consequence of the opioid-sparing effect. The effects of capsaicin with respect to function, however, appeared to be longer lasting, with improved active ROM reported at 14 days.
A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. [2011.08]
OBJECTIVE: To investigate the efficacy and safety of ICX72 or Sinus Buster, a proprietary homeopathic preparation of Capsicum annum and Eucalyptol, versus placebo administered continuously over 2 weeks in subjects with a significant component of nonallergic rhinitis (NAR)... CONCLUSION: This is the first controlled trial demonstrating intranasal capsaicin, when used continuously over 2 weeks, rapidly and safely improves symptoms in rhinitis subjects with a significant NAR component. Copyright (c) 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Clinical Trials Related to Qutenza (Capsaicin)
Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch [Recruiting]
The Summary of product characteristics (SmPC) for QUTENZA advises that topical anaesthetic
is applied prior to the application of QUTENZA. This is a multi-center, randomized,
assessor-blinded study which will investigate the use of an oral analgesic as an alternative
form of pre-treatment for QUTENZA.
Acute Response Capsaicin Flare Study [Recruiting]
Prior to administering PF-04427429 to patients we wish to increase the understanding of
functional effects associated with calcitonin gene related peptide (CGRP) pathways. This
study will examine whether it is possible for a single dose of PF-04427429 to acutely
attenuate a capsaicin induced flare response.
Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage [Recruiting]
In this study all patients will be treated with the same medicine, the QUTENZA patch.
Subjects will receive up to 6 QUTENZA patch applications over 12 months.
Qutenza«-Remodulin« in Pulmonary Arterial Hypertension Patients [Recruiting]
The investigators hypothesise that pre-application of Qutenza« patches to the skin may
reduce pain at the site of Remodulin« SC infusion (sited 1 to 2 weeks later at the site of
Qutenza pre-application), in which case it would greatly improve the quality of life of the
patients, and enable many more to continue with this treatment. It may also provide new
information to support the use of Qutenza« patches for preventing and reducing pain produced
The present study will explore the efficacy of single applications of Qutenza┬« (capsaicin 8%
patch) in reducing site pain caused by continuous SC infusion of Remodulin┬«, in pulmonary
arterial hypertension patients, as assessed by changes in subjective pain rating score
and/or pain and sensory testing.
Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain [Not yet recruiting]
Chronic neck pain is a common condition that can negatively impact quality of life.
Substance P is one of the chemicals in the body that can transmit pain signals from
overloaded neck muscles to the brain. Topical capsaicin blocks the action of Substance P by
releasing, and subsequently depleting the body's store of Substance P in the nerves.
Topical capsaicin has been reported to be an effective therapy for a number of persistent
pain conditions including diabetic neuropathy, post-herpetic neuralgia, osteoarthritis,
rheumatoid arthritis, and post-mastectomy pain. This study will evaluate the efficacy of
topical capsaicin to reduce pain and improve health-related quality of life in adults with
chronic muscular neck pain.
Reports of Suspected Qutenza (Capsaicin) Side Effects
Application Site Pain (26),
Application Site Erythema (15),
Condition Aggravated (8),
Application Site Swelling (5),
Application Site Pruritus (5),
Application Site Vesicles (5), more >>